{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T04:19:30Z","timestamp":1697689170527},"reference-count":39,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2482,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2001,9,20]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold> Recent successes in HIV therapy have uncovered other health problems for HIV\u2010infected individuals. Hepatitis C has become an especially significant problem, partly due to its faster progression in an immunocompromised setting. In addition, the higher viral loads in coinfected patients likely result in more efficient perinatal and perhaps even sexual transmission. Therapy has largely been neglected, despite data suggesting its efficacy in HIV\u2013HCV coinfected patients. Studies of combination interferon and ribavirin studies are lacking, although underway. A major concern is the potential inactivation of certain thymidine analogues by ribavirin. Some antiretroviral therapies, such as ritonavir, indinavir and nevirapine, may enhance liver toxicity in coinfected patients and should be avoided if possible. The role of chronic low\u2010grade liver function abnormalities remains uncertain and requires further investigation. (Intern Med J 2001; 31: 418\u2013421)<\/jats:p>","DOI":"10.1046\/j.1445-5994.2001.00100.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:15:52Z","timestamp":1047435352000},"page":"418-421","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human immunodeficiency virus\u2013hepatitis C coinfection: swapping new problems for newer ones"],"prefix":"10.1111","volume":"31","author":[{"given":"J.","family":"Sasadeusz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_2_2_2","unstructured":"MerrickS SepkowitzK BoyleB JacobsJ.Seroprevalence of hepatitis C antibody and hepatitis B surface antigenemia in a large urban HIV clinic. In: Proceedings of the 12th World AIDS Conference; 1998 Jun 29\u2013Jul 3; Geneva Switzerland. Abstract 22 263."},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/520281"},{"key":"e_1_2_2_4_2","unstructured":"MurillC WeeksH LambertSet al.Age specific trends in seroprevalence of HIV and hepatitis B and C virus among injection drug users admitted to drug treatment in six U.S. cities. In: Proceedings of the 12th World AIDS Conference; 1998 Jun 29\u2013Jul 3; Geneva Switzerland. Abstract 13 224."},{"key":"e_1_2_2_5_2","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus.","volume":"6","author":"Eyster M","year":"1993","journal-title":"J AIDS"},{"key":"e_1_2_2_6_2","first-page":"87","article-title":"Activity of combination therapy with interferon alfa\u20102b plus ribavirin in chronic hepatitis C patients co\u2010infected with HIV.","volume":"1","author":"Dietrich D","year":"1999","journal-title":"Semin Liver Dis Suppl"},{"key":"e_1_2_2_7_2","unstructured":"JusticeA ChangC FuscoJ WestN.Extrapolating long\u2010term HIV\/AIDS survival in the post\u2010HAART era. In: Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sep 26\u201329; San Francisco CA USA. Abstract 1158."},{"key":"e_1_2_2_8_2","unstructured":"CDC.1999 USPHS\/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. United States Public Health Service\/Infectious Diseases Society of America 1999."},{"key":"e_1_2_2_9_2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V84.4.1020.1020","article-title":"Increasing hepatitis C virus RNA levels in hemophiliacs. Relationship to human immunodeficiency virus infection and liver disease.","volume":"84","author":"Eyster M","year":"1994","journal-title":"Blood"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-764"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/515315"},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08312.x"},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01691375"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300409"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199012000-00016"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199510000-00003"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/517808"},{"key":"e_1_2_2_18_2","first-page":"116","article-title":"Enhancement of hepatitis C virus replication and liver damage in HIV\u2010coinfected patients on antiretroviral combination therapy.","volume":"12","author":"Vento S","year":"1998","journal-title":"AIDS"},{"key":"e_1_2_2_19_2","doi-asserted-by":"crossref","unstructured":"RagniM&BontempoF.Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy. J Infect Dis 1999; 180: 2027\u20139.","DOI":"10.1086\/315143"},{"key":"e_1_2_2_20_2","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1128\/jvi.67.10.5823-5832.1993","article-title":"Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH\u20107 cells.","volume":"67","author":"Shih C","year":"1993","journal-title":"J Virol"},{"key":"e_1_2_2_21_2","unstructured":"BochetM Di MartinoV ThibaultVet al.HIV\u2010protease inhibitor therapy decreases the liver fibrosis progression rate in HIV\u2010HCV coinfected patients. In: Proceedings of the 7th Conference on Retroviruses and Opportunistic Infections; 2000 Jan 30\u2013Feb 2; San Francisco CA USA. Abstract 282."},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.74"},{"key":"e_1_2_2_23_2","first-page":"1153","article-title":"Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures worldwide 1997\u20132000.","volume":"49","author":"CDC.","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/313912"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/313594"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/16.1.182"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199804000-00006"},{"key":"e_1_2_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/520144"},{"key":"e_1_2_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1503"},{"key":"e_1_2_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.1.117"},{"key":"e_1_2_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.1.164"},{"key":"e_1_2_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03232-3"},{"key":"e_1_2_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_2_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"e_1_2_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890400206"},{"key":"e_1_2_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(95)91178-2"},{"key":"e_1_2_2_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2435003"},{"key":"e_1_2_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200005050-00010"},{"key":"e_1_2_2_39_2","doi-asserted-by":"crossref","unstructured":"WeiszK GoldmanD TalalA MalicdemM DietrichD.Interferon (IFN) and ribavirin (RBV) therapy for hepatitis C (HCV) in HIV coinfected patients. 12\u2010Month follow up. In: Proceedings of the 7th Conference on Retroviruses and Opportunistic Infections; 2000 Jan 30\u2013Feb 2; San Francisco CA USA. Abstract 283.","DOI":"10.2165\/00128413-200012280-00025"},{"key":"e_1_2_2_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012073432301"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1445-5994.2001.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1445-5994.2001.00100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T14:46:14Z","timestamp":1697640374000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1445-5994.2001.00100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,20]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,9,20]]}},"alternative-id":["10.1046\/j.1445-5994.2001.00100.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1445-5994.2001.00100.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,20]]},"assertion":[{"value":"2008-07-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}